Cardiac and hepatic acyl-CoA and acylcarnitine hydrolase activities in clofibrate-fed rabbitsMOORE, K. H; SOLOMON, F. J.Comparative biochemistry and physiology. C. Comparative pharmacology. 1985, Vol 80, Num 2, pp 355-359, issn 0306-4492Article

Disposition of etofibrate, clofibric and nicotinic acid esters, and their products in dogsGARRETT, E. R; ALTMAYER, P.Journal of pharmaceutical sciences. 1985, Vol 74, Num 3, pp 295-299, issn 0022-3549Article

Hépatotoxicité des hypolipémiantsLARREY, Dominique.Hépato-gastro (Montrouge). 2004, Vol 11, Num 6, pp 407-413, issn 1253-7020, 7 p.Article

The Ebbs and Flows in the Development of Cholesterol-Lowering Drugs: Prospects for the FutureHAJHOSSEINY, R; SABIR, I; KHAVANDI, K et al.Clinical pharmacology and therapeutics. 2014, Vol 96, Num 1, pp 64-73, issn 0009-9236, 10 p.Article

Rapid determination of clofibric acid in human plasma by high-performance liquid chromatographyPAILLET, M; DOUCET, D; MERDJEAN, H et al.Journal of chromatography. 1986, Vol 375, Num 1, pp 179-183, issn 0021-9673Article

Proceedings/Fenofibrate, a third-generation fibric acid derivative, symposium, Dallas TX, November 15, 1986BROWN, W. V.The American journal of medicine. 1987, Vol 83, Num 5, issn 0002-9343, 89 p., BConference Proceedings

Distinction entre patients bons synthétiseurs et bons absorbeurs pour optimiser le traitement hypocholestérolémiant : Thérapeutique = Distinction between good synthesizer and good absorber patients to optimize cholesterol-lowering therapyRADERMECKER, Régis P; SCHEEN, André J.Revue médicale suisse. 2006, Vol 2, Num 76, pp 1910-1915, issn 1660-9379, 6 p.Article

À la découverte de l'ézétimibe = EzetimibeWATKINS, C.La Lettre du cardiologue. 2004, Num 378, pp 44-45, issn 0761-5035, 2 p.Article

Lescol, vastin : Generic name : FluvastatinMALLARKEY, G.Current therapeutics. 1996, Vol 37, Num 4, pp 81-83, issn 0311-905XArticle

Current approaches to drug therapy for the hypercholesterolemic patientWITZTUM, J. L.Circulation (New York, N.Y.). 1989, Vol 80, Num 5, pp 1101-1114, issn 0009-7322, 14 p.Article

Suitability of laboratory animals for screening anti-hyperlipidemic agentsNEELA RAJWADE; DESAI, N. K; JOSHI, V. G et al.Journal of Postgraduate Medicine (Bombay). 1989, Vol 35, Num 3, pp 162-170, issn 0022-3859, 9 p.Article

Manifestations rhumatologiques de certains médicaments : quinolone, hypolipémiants, quinidine = Rheumatologic manifestations of some drugs: quinolone, antilipemic agents, quinidineBOURGEOIS, P; VIGNERON, A.-M; KOEGER, A.-C et al.L' Actualité rhumatologique. 1990, Vol 27, pp 58-67, issn 0065-1818, 10 p.Article

Role of phytosterols in lipid-lowering: current perspectivesGUPTA, A. K; SAVOPOULOS, C. G; AHUJA, J et al.QJM (Oxford. 1994. Print). 2011, Vol 104, Num 4, pp 301-308, issn 1460-2725, 8 p.Article

Statins in dermatologyJOWKAR, Farideh; MOHAMMAD REZA NAMAZI.International journal of dermatology. 2010, Vol 49, Num 11, pp 1235-1243, issn 0011-9059, 9 p.Article

The Acute (Cerebro)Vascular Effects of StatinsPRINZ, Vincent; ENDRES, Matthias.Anesthesia and analgesia. 2009, Vol 109, Num 2, pp 572-584, issn 0003-2999, 13 p.Article

A peri-operative statin update for non-cardiac surgery. Part II: Statin therapy for vascular surgery and peri-operative statin trial designBICCARD, B. M.Anaesthesia. 2008, Vol 63, Num 2, pp 162-171, issn 0003-2409, 10 p.Article

Statins down underMANT, Andrea; LOWINGER, Jocelyn; HALL, Wayne et al.British journal of clinical pharmacology. 2007, Vol 63, Num 1, pp 125-127, issn 0306-5251, 3 p.Article

Mécanismes d'action des hypolipidémiants = Antilipemic agentLUC, G.La Lettre du cardiologue. 2001, Num 343, pp 33-36, issn 0761-5035Article

A Symposium: In Search of the Ideal Lipid-Lowering AgentGOTTO, Antonio M; OLSSON, Anders G.The American journal of cardiology. 2001, Vol 87, Num 5A, issn 0002-9149, 38 p.Conference Proceedings

Cholesterol absorption inhibitorsPROUS, J. R.Drug data report. 1992, Vol 14, pp III-VIII, issn 1579-1793, 33 p., SUP1Serial Issue

Synthesis and anti-hypercholesteremic action of chroman derivativesMATSUDA, H; YAMAHARA, J; OHHATA, K et al.Journal of pharmacobio-dynamics. 1986, Vol 9, Num 10, issn 0386-846X, 137Article

Plasma carnitine and lipid-lowering drugsNESTRUCK, A. C; PANDE, S. V; DAVIGNON, J et al.Atherosclerosis. 1985, Vol 55, Num 3, pp 353-356, issn 0021-9150Article

New lipid-lowering drugs: an updateWIERZBICKI, A. S; HARDMAN, T. C; VILJOEN, A et al.International journal of clinical practice (Esher). 2012, Vol 66, Num 3, pp 270-280, issn 1368-5031, 11 p.Article

Consequences of Succinylcholine Administration to Patients Using StatinsTURAN, Alparslan; MENDOZA, Maria L; GUPTA, Shipra et al.Anesthesiology (Philadelphia). 2011, Vol 115, Num 1, pp 28-35, issn 0003-3022, 8 p.Article

Statin induced myopathySATHASIVAM, Sivakumar; LECKY, Bryan.BMJ. British medical journal (International ed.). 2008, Vol 337, Num 7679, pp 1159-1162, issn 0959-8146, 4 p.Article